Mesothelioma | Mesothelioma news | Breaking lung cancer news | Mesothelioma

News

Advertisers:

Swiss OK for Bayer/Onyx' Nexavar

... Last week, Bayer said it planned to acquire Schering for about $19.7 billion, with the new company's drugmaking activities to be concentrated in a Berlin-based division called Bayer Schering Pharmaceuticals.

The offer was 12% higher than an earlier hostile takeover bid by Merck KGaA, and the latter has said it will not increase its offer for Schering.

The fundraising is part of the companyâ€šs previously announced equity capital raising measures aimed at bringing in up to 4 billion euros.

Relevant Newsonline articles:Mixed feeling over Bayer resultsBayer/Onyx start Ph III trial of Nexavar for NSCLCNexavar cleared in USA for kidney cancerBayer and Onyx seek European OK for cancer drugBayer and Onyx complete kidney cancer drug filingBayer/Onyx' drug improves liver cancer outlook Other sources:http://www.bayer.comhttp://www.onyx.comhttp://www.swissmedic.chemail this pageback to headlines disclaimer site design by DJM ...